vaccine

Marco Ferrari, Al Arabiya English This year’s G20 summit will be an event quite unlike any in the organization’s history. Hosted by Saudi Arabia, the Leaders’ Summit will bring leaders from 19 of the most powerful countries and the European…

Pfizer and BioNTech have surprised the world, and given it hope, with the preliminary results of the Phase 3 clinical trial of their coronavirus vaccine. They announced on Nov. 9 that the early analysis of the data from the Phase…

In a landmark move, India and South Africa on 2 October asked the World Trade Organization (WTO) to allow all countries to choose to neither grant nor enforce patents and other intellectual property (IP) related to COVID-19 drugs, vaccines, diagnostics and other technologies for the duration of the…

By Jhon Sánchez The anti-vaccine movement has undermined the efforts made in different parts of the world to eradicate polio, measles, and other viral diseases. In 2019, Pakistan reported a resurgence of almost eradicated polio after political leaders campaigned against the vaccine.…

As the number of confirmed COVID-19 cases worldwide approaches 4 million and the pandemic could be with us for months or years, we look at who can access drugs like Remdesivir, being developed by pharmaceutical giant Gilead, which has the patent…

By Countercurrents Collective Researchers at the University of Pittsburgh School of Medicine and UPMC, the school’s medical center, are working on a possible vaccine for SARS-CoV-2, the virus that causes COVID-19. Scientists announced news of the potential vaccine, which has…

By John Scales Avery The urgent need for a vaccine Public health experts say that if the COVID-19 epidemic is not successfully contained, it could become a global pandemic, perhaps spreading to 80% of the world’s population. With a 1%…

By Democracy Now! The African Union is holding an emergency meeting on the Ebola outbreak in West Africa. More than 2,000 people have been killed, and the United Nations has warned the toll could hit 20,000 before the virus is…

Published by Science : “We report that the PfSPZ Vaccine—composed of attenuated, aseptic, purified, cryopreserved PfSPZ—was safe and well-tolerated when administered four to six times intravenously (IV) to 40 adults…These data indicate that there is a dose-dependent immunological threshold for…